This document is formulated as a binding legal agreement, emphasizing aspects of intellectual property on data and medical liability disclaimer (due to the risks associated with obesity treatment).
Terms of Use and Access to the Database – Wegovy Portal
Last Updated: December 3, 2025 Website Operator: Nordic Health Data ApS (Copenhagen, Denmark) Website Address: https://xn--5dbbiabwd.com
Introduction Welcome to the information portal “Wegovy” (hereinafter: “the platform” or “the site“). The platform is managed by Nordic Health Data ApS, a technology company registered in Denmark (hereinafter: “the company“). Use of the platform, including viewing data, graphs, studies, and articles presented herein, is subject to the terms outlined below (hereinafter: “the regulations“).
Accessing and using the site constitutes absolute and unconditional agreement to the terms of this regulation. If you do not agree to the terms, you must refrain from any use of the platform.
Chapter A: Definitions and Nature of the Service
1. Definitions
-
“The information”: All data presented on the site, including clinical reviews, statistical analyses, dosage tables, infographics, text, and code.
-
“The user”: Any individual or legal entity browsing the site or using the information contained therein.
2. Nature of the site: Analysis and Information (Non-commercial) The company operates the site as an independent knowledge resource in the field of pharmacological treatment of obesity. Non-commercial statement:
-
The site does not operate as an e-commerce platform.
-
The company does not engage in the sale, marketing, distribution, or mediation of medications (including Wegovy, Ozempic, or Saxenda).
-
Medications cannot be ordered through the site. Digital prescriptions cannot be obtained, and financial transactions cannot be conducted. Any inquiries regarding purchases will be dismissed outright.
Chapter B: Professional Liability Disclaimer
3. Research information only The information on the site is based on the analysis of clinical studies (such as STEP studies), publications from health authorities (FDA/EMA), and professional literature. However, the information is provided for educational and research purposes only.
4. No medical advice The data presented on the site does not constitute medical advice, clinical diagnosis, or treatment recommendation. The user acknowledges that:
-
The treatment with Semaglutide 2.4mg (Wegovy) is a complex medical treatment that requires supervision.
-
The statistics presented on the site (regarding weight loss percentages) are research averages and do not guarantee a similar personal outcome.
-
The site should not be relied upon for determining dosages or altering treatment protocols.
5. Risks and side effects The user confirms that they are aware that the use of medications from the GLP-1 family involves risks, including gastrointestinal side effects, a rare risk of pancreatitis, and other risks detailed in the consumer leaflet. The responsibility for the use of the medication lies solely with the user and the treating physician.
Chapter C: Intellectual Property
6. Ownership of the data All copyright and intellectual property rights in the platform – including data processing, presentation (visualization), textual analyses, source code, and design – are the exclusive property of Nordic Health Data ApS.
7. Limited usage license The user may use the information for private, academic, and self-research purposes only. Prohibitions:
-
No copying, reproducing, or distributing the analyses and graphs without written permission.
-
No use of the data for training artificial intelligence algorithms (AI Training).
-
No use of the information to create a competing commercial database.
8. Trademarks The name “Wegovy” is a registered trademark of Novo Nordisk A/S. The use of this name on the site is done under the “fair use” doctrine for identification, review, and analysis of information, and does not imply any business relationship, collaboration, or sponsorship by the drug manufacturer.
Chapter D: User Conduct
9. Proper use The user commits to using the site for legal purposes only. It is prohibited to use the information on the site to obtain prescription medications through illegal means or for fraudulent purposes.
10. Information security The user commits not to perform actions that may harm the integrity of the platform, including automated scraping, injecting malicious code, or attempting to bypass the company’s security mechanisms.
Chapter E: Limitation of Liability and Indemnification
11. AS-IS service The company does not guarantee continuous availability of the site or absolute accuracy of the data in real-time (due to frequent regulatory changes).
12. Disclaimer of liability The company, its managers, and employees shall not be liable for any direct, indirect, consequential, or special damages incurred by the user due to the use of the site.
13. Indemnification The user shall indemnify the company for any damage or expense incurred as a result of a claim arising from their violation of these terms of use.
Chapter VI: Law and Jurisdiction
14. Applicable Law The law applicable to this agreement shall be exclusively the laws of the Kingdom of Denmark (Danish Law).
15. Jurisdiction The exclusive jurisdiction for any legal dispute shall be vested in the competent courts in Copenhagen.
Deliveries Nationwide 24/7
Delivery within an hour!